Prof. Andrew Tutt, Consultant Clinical Oncologist

Prof. Andrew Tutt

Consultant Clinical Oncologist

Book online
|

Prof. Andrew Tutt PhD FRCR MRCP MB ChB

Consultant Clinical Oncologist

PhD FRCR MRCP MB ChB

Prof. Andrew Tutt

Consultant Clinical Oncologist PhD FRCR MRCP MB ChB

Book online
|
PhD FRCR MRCP MB ChB

Areas of expertise

  • Clinical oncology
  • Breast cancer
  • Biological therapy
  • Chemotherapy
  • Radiotherapy

Recommendations for Prof. Tutt

These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.

Recommended by:

  • byMr Nicolas Beechey-Newman, Breast Surgeon

    An internationally-known oncologist, dealing particularly with triple negative breast cancer.

  • byMr Nicolas Beechey-Newman, Breast Surgeon

    An internationally-known oncologist, dealing particularly with triple negative breast cancer.

  • Address

    • London Bridge Hospital

      27 Tooley Street, London, SE1 2PR

    • London Radiotherapy Centre

      Borough Wing, Lower Ground Floor, Guy's Hospital, Great Maze Pond, London, SE1 9RT

    • Private Care at Guy's at London Bridge Hospital

      Great Maze Pond, London, SE1 9RT

    About Prof. Andrew Tutt

    GMC number: 3453450

    Year qualified: 1990

    Place of primary qualification: University of Bristol

    Areas of expertise

    • Breast Cancer
    • Chemotherapy
    • Radiotherapy

    Professional memberships

    Royal College of Radiologists
    Royal College of Physicians
    General Medical Council

    Articles by Prof. Andrew Tutt

    Histological scoring of immune and stromal features in breast and axillary lymph nodes is prognostic for distant metastasis in lymph node-positive breast cancers: prognostic value of histological immune and stromal features

    Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

    Homologous recombination dna repair deficiency and parp inhibition activity in primary triple negative breast cancer

    Roteomics of replicant perfusate detects changes in the metastatic lymph node microenvironment

    Author correction: landscape of somatic mutations in 560 breast cancer whole-genome sequences

    Integrin-mediated macrophage adhesion promotes lymphovascular dissemination in breast cancer

    Pitfalls in assessing stromal tumor infiltrating lymphocytes (stils) in breast cancer

    Controversial issues in the neoadjuvant treatment of triple-negative breast cancer

    Genomic evolution of breast cancer metastasis and relapse